Pietrobono S, Gaudio E, Gagliardi S, Zitani M, et al. Targeting non-canonical activation of GLI1 by the SOX2-BRD4 transcriptional complex improves the efficacy of HEDGEHOG pathway inhibition in melanoma. Oncogene 2021 May 6. pii: 10.1038/s41388-021-01783.
PMID: 33958721